Reassuring Findings for Growth Differences Among ART Kids
(MedPage Today) -- For kids conceived with assisted reproductive technology (ART), early life weight differences didn't appear to linger long into adolescence, researchers reported.
Compared with those who were naturally conceived, children conceived... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 26, 2022 Category: Endocrinology Source Type: news
Comprehensive Telehealth Boosts Outcomes in Poorly Controlled Diabetes
(MedPage Today) -- A comprehensive approach to telemonitoring type 2 diabetes bolstered glucose control in tough-to-manage patients, according to a randomized trial.
Among 200 patients with persistently poorly controlled type 2 diabetes (PPDM... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 25, 2022 Category: Endocrinology Source Type: news
Rising Gestational Diabetes Rates; Updated Hormone Therapy Statement; Insulin Recall
(MedPage Today) -- The U.S. is seeing a rise in gestational diabetes rates, with a 30% jump from 2016 to 2020, the CDC reported.
Among 1,050 U.S. adults ages 45 and older, receiving federal rental assistance through project-based housing was tied... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 21, 2022 Category: Endocrinology Source Type: news
'Senolytic' Therapy Shows Promise in Neovascular Eye Disease
(MedPage Today) -- NEW YORK CITY -- An investigational drug targeting senescent cells achieved sustained improvement in visual acuity in patients with diabetic macular edema (DME) or neovascular age-related macular degeneration (AMD), a small... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 14, 2022 Category: Endocrinology Source Type: news
Demand Rising for 'Bootlegged' Weight-Loss Drug
(MedPage Today) -- Novo Nordisk's weight management drug semaglutide (Wegovy) has been in prolonged short supply due to "unprecedented demand," prompting increased -- and questionable -- interest in compounded formulations of the drug, physicians... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 7, 2022 Category: Endocrinology Source Type: news
T1D Stem Cell Trial Back On; Fifth Grade Obesity; Islet Autoantibodies Predictive
(MedPage Today) -- After being hit with a clinical hold, Vertex Pharmaceuticals announced it's been given the FDA green-light to push forward on its phase I/II trial for the investigative type 1 diabetes stem cell treatment VX-880.
According to... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 6, 2022 Category: Endocrinology Source Type: news
Predicting Post-Surgery T2D Remission; Infertility & Strokes; Cold Thwarts Obesity?
(MedPage Today) -- Testing blood levels of ceramides after Roux-en-Y gastric bypass surgery helped to predict exactly which patients may achieve type 2 diabetes remission within the 2 years after surgery. "[These findings] reveal a new tool in... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 29, 2022 Category: Endocrinology Source Type: news
EASL Roundup: Path to 'Cure' in Hep B? Low-Carb, High-Fat Diet for NAFLD With T2D
(MedPage Today) -- Notable research presented at the European Association for the Study of the Liver (EASL) annual meeting included studies that showed a sustained response to bulevirtide among patients with difficult-to-treat chronic hepatitis... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 29, 2022 Category: Endocrinology Source Type: news
Stating the Case for Early, Aggressive Intervention in Prediabetes
(MedPage Today) -- ORLANDO -- Strong evidence of increased cardiovascular disease (CVD) risk in patients with prediabetes makes a compelling case for aggressive treatment to prevent progression to diabetes, a primary care diabetes specialist... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 28, 2022 Category: Endocrinology Source Type: news
Mixed Bag for Semaglutide in NASH-Related Compensated Cirrhosis
(MedPage Today) -- Although semaglutide (Ozempic) missed its mark in improving liver fibrosis for patients with nonalcoholic steatohepatitis (NASH)-related cirrhosis, improvements were noted in cardiometabolic parameters and other biomarkers, according... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 27, 2022 Category: Endocrinology Source Type: news
Flash of Greater Stroke Risk at Initiation of Oral Contraceptives
(MedPage Today) -- The upfront stroke risk associated with oral contraceptives and hormone replacement therapy (HRT) waned to varying degrees after the first year of use, an observational study found.
U.K. Biobank participants on birth control... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 24, 2022 Category: Endocrinology Source Type: news
New Imcivree Indication; Top Pediatric Endo Hospitals; Contrast Dye & Tots' Thyroids
(MedPage Today) -- The FDA approved a new indication for setmelanotide (Imcivree), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome but rejected a new indication for Alström syndrome, Rhythm Pharmaceuticals... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 21, 2022 Category: Endocrinology Source Type: news
Mortality Rates and Voting; Varenicline and Smoking in African Americans
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 18, 2022 Category: Endocrinology Source Type: news
No Major Thyroid Changes Seen After COVID-19 Vaccination
(MedPage Today) -- Vaccination against COVID-19 appeared safe for people treated for hypothyroidism, researchers reported.
In a population-based study in Hong Kong, vaccination with the BioNTech/Pfizer shot was not tied to an increased risk of... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 15, 2022 Category: Endocrinology Source Type: news
Hormone-Free Hot Flash Drug Succeeds in Phase III Trial
(MedPage Today) -- An investigational, nonhormonal treatment succeeded at quelling hot flashes associated with menopause, according to the phase III SKYLIGHT-2 trial.
In a study of 484 women with moderate-to-severe vasomotor symptoms (VMS), once... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 15, 2022 Category: Endocrinology Source Type: news
